Insider Transactions in Q4 2022 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 17
2022
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
144
-1.02%
|
$6,624
$46.52 P/Share
|
|
Oct 17
2022
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
416
+2.85%
|
-
|
|
Oct 17
2022
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,777
+7.14%
|
-
|